Biotalys Past Earnings Performance

Past criteria checks 0/6

Biotalys's earnings have been declining at an average annual rate of -15.5%, while the Chemicals industry saw earnings growing at 7.2% annually.

Key information

-15.5%

Earnings growth rate

86.1%

EPS growth rate

Chemicals Industry Growth23.2%
Revenue growth raten/a
Return on equity-83.4%
Net Marginn/a
Next Earnings Update21 Mar 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Biotalys makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ENXTBR:BTLS Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 240-16613
31 Mar 240-18715
31 Dec 230-21717
30 Sep 230-22718
30 Jun 230-24720
31 Mar 230-23719
31 Dec 220-23719
30 Sep 220-21617
30 Jun 220-20615
31 Mar 220-18615
31 Dec 210-17614
30 Sep 210-15513
30 Jun 210-13512
31 Mar 210-12412
31 Dec 200-11311
31 Dec 196-1020
31 Dec 183-520
31 Dec 172-310
31 Dec 160-310
31 Dec 150-210
31 Dec 140-210

Quality Earnings: BTLS is currently unprofitable.

Growing Profit Margin: BTLS is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BTLS is unprofitable, and losses have increased over the past 5 years at a rate of 15.5% per year.

Accelerating Growth: Unable to compare BTLS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BTLS is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-6.3%).


Return on Equity

High ROE: BTLS has a negative Return on Equity (-83.44%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies